Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Intellia Therapeutics, Inc. (NTLA) to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but ...

Why Intellia Therapeutics Stock Plummeted by 20% Today — Oct 24th, 2024

Seemingly encouraging results from the lab were met with some notable skepticism....

2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street — Oct 9th, 2024

Should investors follow the advice of big names on Wall Street? One challenge in doing so is that sometimes analysts have very different takes. Fortunately, there's some agreement on other occasions. Consider these two companies: Block(NYSE: SQ) and Intellia Therapeutics(NASDAQ: NTLA). Bo...

This Beaten-Down Stock Could Soar by 354%, According to Wall Street — Nov 4th, 2024

Maybe the Street is a bit too optimistic on this one....

Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds? — Oct 16th, 2024

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds.In this article, we are going to take a look at where Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands against the other promising biotech stocks. Biotechnology stocks are known for their high ris...

Intellia Therapeutics Announces New Date for Upcoming Investor Webcast — Oct 10th, 2024

Intellia Therapeutics, Inc. - Investor webcast to review the NTLA-2002 Phase 2 data is now planned for Thursday, October 24 at 8:30 a.m. ET CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused...

Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds? — Oct 16th, 2024

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds.In this article, we are going to take a look at where Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands against the other promising biotech stocks. Biotechnology stocks are known for their high ris...

This Beaten-Down Stock Could Soar by 354%, According to Wall Street — Nov 4th, 2024

Maybe the Street is a bit too optimistic on this one....

Intellia Therapeutics Announces New Date for Upcoming Investor Webcast — Oct 10th, 2024

Intellia Therapeutics, Inc. - Investor webcast to review the NTLA-2002 Phase 2 data is now planned for Thursday, October 24 at 8:30 a.m. ET CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused...

Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds? — Oct 16th, 2024

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds.In this article, we are going to take a look at where Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands against the other promising biotech stocks. Biotechnology stocks are known for their high ris...

This Beaten-Down Stock Could Soar by 354%, According to Wall Street — Nov 4th, 2024

Maybe the Street is a bit too optimistic on this one....

Why Intellia Therapeutics Stock Plummeted by 20% Today — Oct 24th, 2024

Seemingly encouraging results from the lab were met with some notable skepticism....

This Beaten-Down Stock Could Soar by 354%, According to Wall Street — Nov 4th, 2024

Maybe the Street is a bit too optimistic on this one....

Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Intellia Therapeutics, Inc. (NTLA) to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but ...

Intellia Therapeutics Announces New Date for Upcoming Investor Webcast — Oct 10th, 2024

Intellia Therapeutics, Inc. - Investor webcast to review the NTLA-2002 Phase 2 data is now planned for Thursday, October 24 at 8:30 a.m. ET CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused...

2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street — Oct 9th, 2024

Should investors follow the advice of big names on Wall Street? One challenge in doing so is that sometimes analysts have very different takes. Fortunately, there's some agreement on other occasions. Consider these two companies: Block(NYSE: SQ) and Intellia Therapeutics(NASDAQ: NTLA). Bo...

2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street — Oct 9th, 2024

Should investors follow the advice of big names on Wall Street? One challenge in doing so is that sometimes analysts have very different takes. Fortunately, there's some agreement on other occasions. Consider these two companies: Block(NYSE: SQ) and Intellia Therapeutics(NASDAQ: NTLA). Bo...

NTLA Begins Phase III Study on Hereditary Angioedema Candidate — Oct 8th, 2024

Intellia Therapeutics, Inc. NTLA announced that it has initiated the pivotal phase III HAELO study evaluating NTLA-2002 for the treatment of hereditary angioedema (HAE). The global double-blind, placebo-controlled study will evaluate the safety and efficacy of NTLA-2002 in adults with Typ...

This Beaten-Down Stock Could Soar by 354%, According to Wall Street — Nov 4th, 2024

Maybe the Street is a bit too optimistic on this one....

Intellia Therapeutics Announces New Date for Upcoming Investor Webcast — Oct 10th, 2024

Intellia Therapeutics, Inc. - Investor webcast to review the NTLA-2002 Phase 2 data is now planned for Thursday, October 24 at 8:30 a.m. ET CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused...

Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Intellia Therapeutics, Inc. (NTLA) to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but ...

Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Intellia Therapeutics, Inc. (NTLA) to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but ...

Why Intellia Therapeutics Stock Plummeted by 20% Today — Oct 24th, 2024

Seemingly encouraging results from the lab were met with some notable skepticism....

Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds? — Oct 16th, 2024

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds.In this article, we are going to take a look at where Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands against the other promising biotech stocks. Biotechnology stocks are known for their high ris...

NTLA Begins Phase III Study on Hereditary Angioedema Candidate — Oct 8th, 2024

Intellia Therapeutics, Inc. NTLA announced that it has initiated the pivotal phase III HAELO study evaluating NTLA-2002 for the treatment of hereditary angioedema (HAE). The global double-blind, placebo-controlled study will evaluate the safety and efficacy of NTLA-2002 in adults with Typ...

2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street — Oct 9th, 2024

Should investors follow the advice of big names on Wall Street? One challenge in doing so is that sometimes analysts have very different takes. Fortunately, there's some agreement on other occasions. Consider these two companies: Block(NYSE: SQ) and Intellia Therapeutics(NASDAQ: NTLA). Bo...

Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Intellia Therapeutics, Inc. (NTLA) to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but ...

This Beaten-Down Stock Could Soar by 354%, According to Wall Street — Nov 4th, 2024

Maybe the Street is a bit too optimistic on this one....

Intellia Therapeutics Announces New Date for Upcoming Investor Webcast — Oct 10th, 2024

Intellia Therapeutics, Inc. - Investor webcast to review the NTLA-2002 Phase 2 data is now planned for Thursday, October 24 at 8:30 a.m. ET CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused...

Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds? — Oct 16th, 2024

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds.In this article, we are going to take a look at where Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands against the other promising biotech stocks. Biotechnology stocks are known for their high ris...

Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds? — Oct 16th, 2024

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds.In this article, we are going to take a look at where Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands against the other promising biotech stocks. Biotechnology stocks are known for their high ris...

Intellia Therapeutics Announces New Date for Upcoming Investor Webcast — Oct 10th, 2024

Intellia Therapeutics, Inc. - Investor webcast to review the NTLA-2002 Phase 2 data is now planned for Thursday, October 24 at 8:30 a.m. ET CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused...

This Beaten-Down Stock Could Soar by 354%, According to Wall Street — Nov 4th, 2024

Maybe the Street is a bit too optimistic on this one....

Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds? — Oct 16th, 2024

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds.In this article, we are going to take a look at where Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands against the other promising biotech stocks. Biotechnology stocks are known for their high ris...

This Beaten-Down Stock Could Soar by 354%, According to Wall Street — Nov 4th, 2024

Maybe the Street is a bit too optimistic on this one....

Intellia Therapeutics Announces New Date for Upcoming Investor Webcast — Oct 10th, 2024

Intellia Therapeutics, Inc. - Investor webcast to review the NTLA-2002 Phase 2 data is now planned for Thursday, October 24 at 8:30 a.m. ET CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused...

Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Intellia Therapeutics, Inc. (NTLA) to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but ...

2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street — Oct 9th, 2024

Should investors follow the advice of big names on Wall Street? One challenge in doing so is that sometimes analysts have very different takes. Fortunately, there's some agreement on other occasions. Consider these two companies: Block(NYSE: SQ) and Intellia Therapeutics(NASDAQ: NTLA). Bo...

Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Intellia Therapeutics, Inc. (NTLA) to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but ...

Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Intellia Therapeutics, Inc. (NTLA) to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but ...

This Beaten-Down Stock Could Soar by 354%, According to Wall Street — Nov 4th, 2024

Maybe the Street is a bit too optimistic on this one....

2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street — Oct 9th, 2024

Should investors follow the advice of big names on Wall Street? One challenge in doing so is that sometimes analysts have very different takes. Fortunately, there's some agreement on other occasions. Consider these two companies: Block(NYSE: SQ) and Intellia Therapeutics(NASDAQ: NTLA). Bo...

Intellia Therapeutics, Inc. (NTLA) the Most Promising Biotech Stock According to Hedge Funds? — Oct 16th, 2024

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds.In this article, we are going to take a look at where Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands against the other promising biotech stocks. Biotechnology stocks are known for their high ris...

This Beaten-Down Stock Could Soar by 354%, According to Wall Street — Nov 4th, 2024

Maybe the Street is a bit too optimistic on this one....

2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street — Oct 9th, 2024

Should investors follow the advice of big names on Wall Street? One challenge in doing so is that sometimes analysts have very different takes. Fortunately, there's some agreement on other occasions. Consider these two companies: Block(NYSE: SQ) and Intellia Therapeutics(NASDAQ: NTLA). Bo...

This Beaten-Down Stock Could Soar by 354%, According to Wall Street — Nov 4th, 2024

Maybe the Street is a bit too optimistic on this one....

Intellia Therapeutics Announces New Date for Upcoming Investor Webcast — Oct 10th, 2024

Intellia Therapeutics, Inc. - Investor webcast to review the NTLA-2002 Phase 2 data is now planned for Thursday, October 24 at 8:30 a.m. ET CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused...

Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? — Oct 17th, 2024

The market expects Intellia Therapeutics, Inc. (NTLA) to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but ...

NTLA Begins Phase III Study on Hereditary Angioedema Candidate — Oct 8th, 2024

Intellia Therapeutics, Inc. NTLA announced that it has initiated the pivotal phase III HAELO study evaluating NTLA-2002 for the treatment of hereditary angioedema (HAE). The global double-blind, placebo-controlled study will evaluate the safety and efficacy of NTLA-2002 in adults with Typ...

2 Cathie Wood Stocks That Could Soar 32% and 282%, According to Wall Street — Oct 9th, 2024

Should investors follow the advice of big names on Wall Street? One challenge in doing so is that sometimes analysts have very different takes. Fortunately, there's some agreement on other occasions. Consider these two companies: Block(NYSE: SQ) and Intellia Therapeutics(NASDAQ: NTLA). Bo...